With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker fkansteiner Fri, 12/02/2022 – 09:51 More: With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker Source: fierce
read moreFierce Pharma Asia—Eisai’s lecanemab Alzheimer’s debate; BeiGene’s Imbruvica showdown; Shionogi’s COVID drug nod aliu Fri, 12/02/2022 – 08:55 More: Fierce Pharma Asia—Eisai's lecanemab Alzheimer's debate; BeiGene's Imbruvica showdown; Shionogi's COVID drug nod Source: fierce
read morePositive scientific opinion by EMA would create pathway for arpraziquantel in African endemic countries More: Merck KGaA’s arpraziquantel validated by European Medicines Agency Source: News
read morePatients and service users routinely struggle to access mental healthcare across the NHS More: Healthcare leaders warn about unsustainable pressure on mental health services Source: News
read moreEli Lilly dumps Innovent’s PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug aliu Thu, 12/01/2022 – 15:03 More: Eli Lilly dumps Innovent's PD-1 after FDA rebuff, nixing high-profile Chinese cancer drug Source: fierce
read moreWith J&J’s Gorsky departing, Duato adopts dual role as chairman and CEO zbecker Thu, 12/01/2022 – 11:20 More: With J&J's Gorsky departing, Duato adopts dual role as chairman and CEO Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals